Clinical Trials Logo

Clinical Trial Summary

The general scope of the study involves meditation and its effects on pain management, narcotic use, and emotional well-being. Half of the participants will receive access to a meditation app, which they will be asked to use for at least 10 minutes every day for 6 weeks, while the other participants will be in the waitlist group and will receive a subscription to the meditation app after the 6 week study period ends. All participants will be asked to complete a set of questionnaires


Clinical Trial Description

Chronic pain affects an estimated 11.2% of the US population, costs the United States approximately $635 billion per year in medical expenses and lost productivity, and fuels the current epidemic of opioid addiction. Understanding alternate approaches to chronic pain management is an imperative given new guidelines for the treatment of pain, and preliminary studies indicate that meditation programs may reduce the suffering and distress that accompanies chronic pain. However, much of the research on meditation for pain has examined the effects of scheduled group interventions, delivered in-person by instructors over the course of several weeks. Far less research has looked at the delivery method that is most common and arguably most sustainable for busy adults, namely, smart phone delivered Contemplative Applications (Apps) for Well-being (CAWs). The proposed study will examine the use and impact of a meditation apps in the context of pain. Participants will be randomized to either app or a wait-list group, and will be assessed in terms of self-reported pain, distress, narcotic use. To assess efficacy, the researchers will examine the longitudinal changes in all measures in the mindfulness app group, compared to wait-list control groups. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03495726
Study type Interventional
Source Emory University
Contact Jennifer Mascaro, PhD
Phone 404-558-4461
Email jmascar@emory.edu
Status Recruiting
Phase N/A
Start date June 5, 2018
Completion date April 2020

See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Recruiting NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Recruiting NCT03298269 - Behavioral Interventions for Chronic Pain and Opioid-Related Problems N/A
Recruiting NCT03675386 - Reducing Opioid Use for Chronic Pain Patients Following Surgery N/A
Not yet recruiting NCT03669939 - Toward Safer Opioid Prescribing for Chronic Pain in High Risk Populations
Recruiting NCT02944786 - Help Overcoming Pain Early - an Adolescent-centered School Health Prevention Program N/A
Recruiting NCT02723929 - Effects of tDCS and tUS on Pain Perception in OA of the Knee N/A
Recruiting NCT02925364 - Functional and Anatomical MRI of the Spinal Cord and Peri-spinal Tissues
Recruiting NCT02902796 - Comparison of 1000 Hertz (Hz), Burst, and Standard Spinal Cord Stimulation in Chronic Pain Relief Phase 4
Active, not recruiting NCT02946073 - Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain Phase 3
Not yet recruiting NCT02903303 - Hypnosis as a Potentiation Technique for the Interventional Treatment of Chronic Lumbar Pain N/A
Completed NCT02977208 - Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use Phase 4
Recruiting NCT03158376 - Preoperative Gabapentin for Chronic Pain After Thoracotomy (GABATHOMIE). Phase 3
Withdrawn NCT02445677 - Using TENS to Relieve Pain and Potentiate the Rehabilitation of Pain Patients N/A
Completed NCT02531282 - Effect of a Health Promotion Intervention for People With Chronic Pain at a Healthy Life Centre N/A
Completed NCT02778555 - Development and Validation of a Daily Pain Catastrophizing Scale N/A
Recruiting NCT02192398 - Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH) N/A
Recruiting NCT02262234 - Education Interventions for Self-Management of Pain Post-SCI: A Pilot Study Phase 1/Phase 2